metaxalone

Generic: metaxalone

Labeler: sciegen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name metaxalone
Generic Name metaxalone
Labeler sciegen pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

metaxalone 400 mg/1

Manufacturer
ScieGen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 50228-474
Product ID 50228-474_2fa7c2d7-03c0-4f7e-aa18-d586e157e177
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207466
Listing Expiration 2026-12-31
Marketing Start 2020-04-30

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50228474
Hyphenated Format 50228-474

Supplemental Identifiers

RxCUI
197935 351254
UPC
0350228323055 0350228323017 0350228323307 0350228474108 0350228474306
UNII
1NMA9J598Y
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name metaxalone (source: ndc)
Generic Name metaxalone (source: ndc)
Application Number ANDA207466 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (50228-474-10)
  • 30 TABLET in 1 BOTTLE (50228-474-30)
source: ndc

Packages (2)

Ingredients (1)

metaxalone (400 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2fa7c2d7-03c0-4f7e-aa18-d586e157e177", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0350228323055", "0350228323017", "0350228323307", "0350228474108", "0350228474306"], "unii": ["1NMA9J598Y"], "rxcui": ["197935", "351254"], "spl_set_id": ["1cef46bb-e590-4a58-82e0-7cf1fc3836a5"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["ScieGen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (50228-474-10)", "package_ndc": "50228-474-10", "marketing_start_date": "20200430"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50228-474-30)", "package_ndc": "50228-474-30", "marketing_start_date": "20200430"}], "brand_name": "Metaxalone", "product_id": "50228-474_2fa7c2d7-03c0-4f7e-aa18-d586e157e177", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "50228-474", "generic_name": "Metaxalone", "labeler_name": "ScieGen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Metaxalone", "active_ingredients": [{"name": "METAXALONE", "strength": "400 mg/1"}], "application_number": "ANDA207466", "marketing_category": "ANDA", "marketing_start_date": "20200430", "listing_expiration_date": "20261231"}